Use of Pre-Emptive Pudendal Nerve Block for Pelvic Reconstructive Surgery
A Randomized Controlled Trial of Use of Pre-emptive Pudendal Nerve Block for Pelvic Reconstructive Surgery
調査の概要
詳細な説明
Subjects will have a through physical exam with evolution of the pelvis support using the POP-Q (pelvic organ prolapse quantification) system. All subjects will need to sign informed consent pre-approved by the IRB. The subjects, surgeons, and anesthesiologist will all be blinded to the injected material. The OR Scrub nurse will given the envelope at the start of each case and asked to draw the material into a syringe. All subjects will receive general anesthesia. Subjects will be randomized to receive preemptive pudendal nerve blockade with 10 ml of 0 .5 % Bupivacaine with epinephrine or normal saline to each side. The allocation schedule is computer generated using random-numbers table concealed in opaque envelops. Once the patient receives general anesthesia she will be positioned appropriately in dorsal lithotomy with padded Allan stir ups. 10 ml of Bupivacaine will be injected on either side using the Iowa trumpet pudendal needle drive to direct and guide appropriate position. Aspiration was attempted for every injection to decrease the chance of intravascular infusion.
At the completion of the surgery the subjects will be brought to the PACU for care. Patients are assessed immediately upon arrival to the PACU. The patients are asked their pain level using the VAS pain scale/ modified surgical pain scale at hours 1 and 2 post op. All patients are given a prescription for Vicoprofen 7.5/200mg at their pre-op visit and asked to have it filled prior to their surgery. Patients have the option to go home the same day of surgery as long as their pain is well controlled and they are clinically stable for discharge. Continued pain management and pain scale assessment will be done at 4 hours, and post op day 1 and 2. A medication log will be kept for 2 weeks post op, detailing the number of pain medications taken during that period.
研究の種類
段階
- 適用できない
連絡先と場所
研究場所
-
-
New York
-
New York、New York、アメリカ、10029
- ICAHN School of Medicine at Mount Sinai
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- The ability to read and understand English
- Be at least 18 years old
- Symptomatic Stage 2 prolapse
Exclusion Criteria:
- Intolerance to local anesthetics or narcotics
- History of major psychiatric disorder or chronic pain syndrome
- History of substance abuse or current narcotic use
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:支持療法
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:4倍
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
アクティブコンパレータ:pudendal block
preemptive pudendal nerve blockade with 10 ml of 0 .5 % Bupivacaine with epinephrine.
10 ml of Bupivacaine will be injected on either side using the pudendal nerve block tray.
|
preemptive pudendal nerve blockade with 10 ml of 0 .5 % Bupivacaine with epinephrine.
他の名前:
|
|
プラセボコンパレーター:no pudendal block
Saline
|
preemptive pudendal nerve blockade with 10 ml of normal saline to each side
他の名前:
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
時間枠 |
|---|---|
|
VAS pain scale
時間枠:up to 2 weeks
|
up to 2 weeks
|
二次結果の測定
結果測定 |
時間枠 |
|---|---|
|
post operative analgesic consumption
時間枠:up to 2 weeks
|
up to 2 weeks
|
|
adverse effect of the pudendal block
時間枠:up to 2 weeks
|
up to 2 weeks
|
|
Length of hospital stay
時間枠:up to 2 weeks
|
up to 2 weeks
|
|
Medical or surgical complications
時間枠:up to 2 weeks
|
up to 2 weeks
|
協力者と研究者
捜査官
- 主任研究者:Mamta Mamik, MD、ICAHN School of Medicine at Mount Sinai
出版物と役立つリンク
一般刊行物
- Ke RW, Portera SG, Bagous W, Lincoln SR. A randomized, double-blinded trial of preemptive analgesia in laparoscopy. Obstet Gynecol. 1998 Dec;92(6):972-5. doi: 10.1016/s0029-7844(98)00303-2.
- Katz J, Kavanagh BP, Sandler AN, Nierenberg H, Boylan JF, Friedlander M, Shaw BF. Preemptive analgesia. Clinical evidence of neuroplasticity contributing to postoperative pain. Anesthesiology. 1992 Sep;77(3):439-46. doi: 10.1097/00000542-199209000-00006.
- Schierup L, Schmidt JF, Torp Jensen A, Rye BA. Pudendal block in vaginal deliveries. Mepivacaine with and without epinephrine. Acta Obstet Gynecol Scand. 1988;67(3):195-7. doi: 10.3109/00016348809004200.
研究記録日
主要日程の研究
研究開始
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
pudendal blockの臨床試験
-
Amber Therapeutics Ltd募集
-
Cairo Universityわからない
-
Erzurum Regional Training & Research Hospital完了